Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

[Sleep disorders and stroke: data of the esse-rf study].

Bochkarev MV, Korostovtseva LS, Medvedeva EA, Rotar OP, Sviryaev YV, Zhernakova YV, Shalnova SA, Konradi AO, Chazova IE, Boitsov SA, Shlyakhto EV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(4. Vyp. 2):73-80. doi: 10.17116/jnevro201911904273. Russian.

PMID:
31317919
2.

Multiple rare and common variants in APOB gene locus associated with oxidatively modified low-density lipoprotein levels.

Khlebus E, Kutsenko V, Meshkov A, Ershova A, Kiseleva A, Shevtsov A, Shcherbakova N, Zharikova A, Lankin V, Tikhaze A, Chazova I, Yarovaya E, Drapkina O, Boytsov S.

PLoS One. 2019 May 31;14(5):e0217620. doi: 10.1371/journal.pone.0217620. eCollection 2019.

3.

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension.

Danilov NM, Matchin YG, Chernyavsky AM, Edemsky AG, Grankin DS, Sagaydak OV, Chazova IE, Boytsov SA, Karaskov AM.

Ter Arkh. 2019 May 16;91(4):43-47. doi: 10.26442/00403660.2019.04.000100.

PMID:
31094475
4.

The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation.

Stukalova OV, Gupalo EM, Chumachenko PV, Samko AN, Butorova EA, Shakhnovich RM, Mironova NA, Narusov OY, Safiullina AA, Shariya MA, Golitsyn SP, Ternovoy SK, Chazova IE.

Ter Arkh. 2019 May 16;91(4):28-36. doi: 10.26442/00403660.2019.04.000078.

PMID:
31094473
5.

Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension".

Chazova IE, Martynyuk TV.

Ter Arkh. 2019 Mar 30;91(3):114-116. doi: 10.26442/00403660.2019.03.000185. No abstract available.

PMID:
31094469
6.

Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension).

Chazova IE, Lazareva NV, Oshchepkova EV.

Ter Arkh. 2019 Mar 29;91(3):4-10. doi: 10.26442/00403660.2019.03.000110.

PMID:
31094451
7.

Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.

Chazova IE, Arkhipova OA, Martynyuk TV.

Ter Arkh. 2019 Mar 10;91(1):24-31. doi: 10.26442/00403660.2019.01.000024.

PMID:
31090367
8.

Clinical features of arterial hypertension in men and women (according to the National Registry of Arterial Hypertension).

Chazova IE, Aksenova AV, Oschepkova EV.

Ter Arkh. 2019 Mar 2;91(1):8-16. doi: 10.26442/00403660.2019.01.000021.

PMID:
31090364
9.

May Measurement Month 2017 in Russia: hypertension treatment and control-Europe.

Rotar O, Konradi A, Tanicheva A, Nakonechnikov S, Blinova N, Beaney T, Xia X, Poulter NR, Chazova I, Shlyakhto E.

Eur Heart J Suppl. 2019 Apr;21(Suppl D):D101-D103. doi: 10.1093/eurheartj/suz068. Epub 2019 Apr 24.

10.

Overweight and Obesity in the Russian Population: Prevalence in Adults and Association with Socioeconomic Parameters and Cardiovascular Risk Factors.

Kontsevaya A, Shalnova S, Deev A, Breda J, Jewell J, Rakovac I, Conrady A, Rotar O, Zhernakova Y, Chazova I, Boytsov S.

Obes Facts. 2019;12(1):103-114. doi: 10.1159/000493885. Epub 2019 Mar 7.

11.

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension.

Martynyuk TV, Nakonechnikov SN, Chazova IY.

Ter Arkh. 2018 Apr 19;90(4):72-80. doi: 10.26442/terarkh201890472-80. Review.

PMID:
30701878
12.

Modern view on the place of riociguat in the treatment of pulmonary hypertension.

Valieva ZS, Taran IN, Martynyuk TV, Chazova IY.

Ter Arkh. 2018 Apr 19;90(4):55-59. doi: 10.26442/terarkh201890455-59. Review.

PMID:
30701875
13.

Management of acute coronary syndrome in older adults (data from russian federal acute coronary syndrome registry).

Ocshepkova EV, Sagaydak OV, Chazova IE.

Ter Arkh. 2018 Apr 19;90(3):67-71. doi: 10.26442/terarkh201890367-71.

PMID:
30701859
14.

Interrelation of erectile dysfunction with obesity in patients with arterial hypertension.

Alekseeva TA, Shariya MA, Gamidov SI, Elfimova EM, Starostin IV, Litvin AY, Chazova IE.

Ter Arkh. 2018 Dec 30;90(12):84-89. doi: 10.26442/00403660.2018.12.000013.

PMID:
30701838
15.

The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome.

Elfimova EM, Litvin AY, Chazova IE.

Ter Arkh. 2018 Dec 30;90(12):28-33. doi: 10.26442/00403660.2018.12.000005.

PMID:
30701830
16.

Oxidative and carbonyl stress as a factors of the modification of proteins and DNA destruction in diabetes.

Lankin VZ, Tikhaze AK, Konovalova GG, Odinokova OA, Doroshchuk NA, Chazova IE.

Ter Arkh. 2018 Nov 22;90(10):46-50. doi: 10.26442/terarkh2018901046-50.

PMID:
30701795
17.

The prevalence of abdominal obesity and the association with socioeconomic status in Regions of the Russian Federation, the results of the epidemiological study - ESSE-RF.

Zhernakova YV, Zheleznova EA, Chazova IE, Oshchepkova EV, Dolgusheva YA, Yarovaya EB, Blinova NV, Orlovsky AA, Konosova ID, Shalnova SA, Rotar' OP, Konradi AO, Shlyakhto EV, Boytsov SA.

Ter Arkh. 2018 Nov 22;90(10):14-22. doi: 10.26442/terarkh2018901014-22.

PMID:
30701790
18.

Family hyperaldosteronism type I: a clinical case and review of literature.

Chikladze NM, Favorova OO, Chazova IE.

Ter Arkh. 2018 Sep 20;90(9):115-122. doi: 10.26442/terarkh2018909115-122.

PMID:
30701745
19.

The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.

Chazova IE, Martynyuk TV, Valieva ZS, Nakonechnikov SN, Nedogoda SV, Salasyuk AS, Taran IN, Gratsianskaya SE.

Ter Arkh. 2018 Sep 20;90(9):101-109. doi: 10.26442/terarkh2018909101-109.

PMID:
30701743
20.

Features of the clinics and treatment of patients with obesity and hypertension (according to the National register of arterial hypertension).

Oshchepkova EV, Lazareva NV, Chazova IE.

Ter Arkh. 2018 Sep 20;90(9):8-14. doi: 10.26442/terarkh20189098-14.

PMID:
30701729
21.

Arterial hypertension in the light of current recommendations.

Chazova IE.

Ter Arkh. 2018 Sep 20;90(9):4-7. doi: 10.26442/terarkh20189094-7.

PMID:
30701728
22.

Pulmonary hypertension due to left heart disease.

Vachiéry JL, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, Coghlan G, Chazova I, De Marco T.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801897. doi: 10.1183/13993003.01897-2018. Print 2019 Jan.

23.
24.

[Social-demographic aspects of insomnia in the Russian population according to ESSE-RF study].

Bochkarev MV, Korostovtseva LS, Filchenko IA, Rotar OP, Sviryaev YV, Zhernakova YV, Shalnova SA, Konradi AO, Boitsov SA, Chazova IE, Shlyakhto EV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(4. Vyp. 2):26-34. doi: 10.17116/jnevro20181184226. Russian.

PMID:
30059049
25.

[The State of Vascular Bed, Parenchyma and Perfusion of Lungs in Chronic Thromboembolic Pulmonary Hypertension According to Data of Subtraction Pulmonary Angiography].

Demchenkova AY, Veselova TN, Martynyuk TV, Danilov NM, Mershin KV, Ternovoy SK, Chazova IE.

Kardiologiia. 2018 May;(5):48-56. Russian.

PMID:
29870324
26.

[Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome].

Movsisyan GA, Martynyuk TV, Mershin KV, Danilov NM, Satybaldyeva MA, Reshetnyak TM, Akchurin RS, Nasonov EL, Chazova IY.

Ter Arkh. 2017;89(9):93-99. doi: 10.17116/terarkh201789993-99. Russian.

PMID:
29039836
27.

[Bosentan use in pulmonary arterial hypertension: Russian and foreign experience].

Valieva ZS, Martynyuk TV, Chazova IE.

Ter Arkh. 2017;89(8):95-103. doi: 10.17116/terarkh201789895-103. Review. Russian.

PMID:
28914858
28.

[Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study].

Veselova TN, Demchenkova AY, Martynyuk TV, Danilov NM, Ternovoy SK, Chazova IE.

Ter Arkh. 2017;89(4):8-14. doi: 10.17116/terarkh20178948-14. Russian.

PMID:
28514393
29.

[A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension].

Arkhipova OA, Martynyuk TV, Chazova IE.

Ter Arkh. 2016;88(12):88-93. doi: 10.17116/terarkh2016881288-93. Russian.

PMID:
28139566
30.

[Changes in the receptor activity of β2-adrenoreceptors of human T-lymphocytes under the effect of β2-agonists].

Agapova OY, Skoblov YS, Tkachev GA, Mironova NA, Golitsyn SP, Masenko VP, Chazova IE, Zykov KA.

Mol Biol (Mosk). 2016 Nov-Dec;50(6):999-1006. doi: 10.7868/S0026898416050025. Russian.

31.

Metabolically healthy obese and metabolically unhealthy non-obese phenotypes in a Russian population.

Rotar O, Boyarinova M, Orlov A, Solntsev V, Zhernakova Y, Shalnova S, Deev A, Konradi A, Baranova E, Chazova I, Boytsov S, Shlyakhto E.

Eur J Epidemiol. 2017 Mar;32(3):251-254. doi: 10.1007/s10654-016-0221-z. Epub 2016 Dec 30.

PMID:
28039558
32.

[Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)].

Chazova IE, Martynyuk TV.

Ter Arkh. 2016;88(10):63-73. doi: 10.17116/terarkh201688663-73. Russian.

PMID:
27801422
33.

[Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1)].

Chazova IE, Martynyuk TV.

Ter Arkh. 2016;88(9):90-101. doi: 10.17116/terarkh201688990-101. Russian.

PMID:
27735920
34.

The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension - the VICTORY trial.

Accetto R, Chazova IY, Sirenko Y, Vincelj J, Widimsky J Jr, Barbič-Žagar B.

Kardiol Pol. 2017;75(1):55-64. doi: 10.5603/KP.a2016.0135. Epub 2016 Oct 7.

35.

[A clinical case of hemangioma of the face and tongue concurrent with severe obstructive sleep apnea syndrome complicated by cardiac arrhythmias and conduction disturbances].

Konovalova KI, Elfimova EM, Butorova EA, Aksenova AV, Galitsin PV, Bulkina OS, Litvin AY, Chazova IE.

Ter Arkh. 2016;88(8):105-110. doi: 10.17116/terarkh2016888105-110. Russian.

PMID:
27636935
36.

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, Sliwa K, Dans A, Avezum A, Piegas LS, Keltai K, Keltai M, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Parkhomenko A, Khunti K, Toff WD, Reid CM, Varigos J, Leiter LA, Molina DI, McKelvie R, Pogue J, Wilkinson J, Jung H, Dagenais G, Yusuf S; HOPE-3 Investigators.

N Engl J Med. 2016 May 26;374(21):2009-20. doi: 10.1056/NEJMoa1600175. Epub 2016 Apr 2.

37.

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators.

N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2.

38.

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D, Avezum A, Leiter LA, Piegas LS, Parkhomenko A, Keltai M, Keltai K, Sliwa K, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Accini JL, McKelvie R, Pogue J, Jung H, Liu L, Diaz R, Dans A, Dagenais G; HOPE-3 Investigators.

N Engl J Med. 2016 May 26;374(21):2032-43. doi: 10.1056/NEJMoa1600177. Epub 2016 Apr 2. Erratum in: N Engl J Med. 2018 Oct 11;379(15):1486.

39.

[Radioligand Method of Assessment of β-Adrenoceptor's Activity on Human T-Lymphocytes].

Agapova OY, Skoblov YS, Zykov KA, Rvacheva AV, Beilina VB, Masenko VP, Chazova IE.

Bioorg Khim. 2015 Sep-Oct;41(5):592-8. Russian.

PMID:
26762097
40.

[Cardiotoxicity of trastuzumab: mechanisms of development, diagnosis, treatment].

Ovchinnikov AG, Skorobogatova AV, Seiniglazova TY, Kozyavin NA, Ageev FT, Chazova IE.

Vopr Onkol. 2016;62(6):719-731. Review. Russian.

PMID:
30695558
41.

Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.

Mancia G, Omboni S, Chazova I, Coca A, Girerd X, Haller H, Parati G, Pauletto P, Pupek-Musialik D, Svyshchenko Y; FELT Study Group.

J Hypertens. 2016 Jan;34(1):139-48. doi: 10.1097/HJH.0000000000000767.

PMID:
26630216
42.

[Comorbidity of cardiovascular diseases and cancers: Problems in the diagnosis of cardiotoxic effects of chemo- and radiation therapy].

Chazova IE, Oshchepkova EV, Kantorova AY.

Ter Arkh. 2015;87(9):4-10. doi: 10.17116/terarkh20158794-10. Russian.

PMID:
26591546
43.

Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.

Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, Kunti K, Kim JH, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJ, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S; HOPE-3 Investigators.

Can J Cardiol. 2016 Mar;32(3):311-8. doi: 10.1016/j.cjca.2015.07.001. Epub 2015 Jul 8. Erratum in: Can J Cardiol. 2016 Dec;32(12 ):1573.

PMID:
26481083
44.

[Prevalence of cardiiovascular risk factors in Russian population of patients with arterial hypertension].

Chazova IE, Zhernakova IuV, Oshchepkova EV, Shal'nova SA, Iarovaia EB, Konradi AO, Boĭtsov SA.

Kardiologiia. 2014;54(10):4-12. Russian.

PMID:
25675714
45.

[Pulmonary hypertension in Russia: the first results of the national register].

Chazova IE, Arkhipova OA, Valieva ZS, Nakonechnikov SN, Martyniuk TV.

Ter Arkh. 2014;86(9):56-64. Russian.

PMID:
25518507
46.

[24-hour systolic wave increment index monitoring in patients with low-renin arterial hypertension].

Valieva ZS, Chikhladze NM, Rogoza AN, Iarovaia EB, Bosykh EG, Chazova IE.

Ter Arkh. 2014;86(9):38-44. Russian.

PMID:
25518504
47.

[Clinical guidelines for the diagnosis and treatment of pulmonary hypertension].

Chazova IE, Avdeev SN, Tsareva NA, Volkov AV, Martyniuk TV, Nakonechnikov SN.

Ter Arkh. 2014;86(9):4-23. Russian.

PMID:
25518501
48.

Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension.

Laurent S, Parati G, Chazova I, Sirenko Y, Erglis A, Laucevicius A, Farsang C.

J Hypertens. 2015 Mar;33(3):653-61; discussion 662. doi: 10.1097/HJH.0000000000000440.

PMID:
25479022
49.

Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.

Mancia G, Asmar R, Amodeo C, Mourad JJ, Taddei S, Gamba MA, Chazova IE, Puig JG.

J Hypertens. 2015 Feb;33(2):401-11. doi: 10.1097/HJH.0000000000000409.

PMID:
25380149
50.

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.

Mancia G, Coca A, Chazova I, Girerd X, Haller H, Pauletto P, Pupek-Musialik D, Svyshchenko Y; FELT investigators.

J Hypertens. 2014 Aug;32(8):1700-7; discussion 1707. doi: 10.1097/HJH.0000000000000239. Erratum in: J Hypertens. 2014 Oct;32(10):2106.

Supplemental Content

Loading ...
Support Center